ResolvinD stimulates epithelial wound repair and inhibits TGF-ß-induced EMT whilst reducing fibroproliferation and collagen production. (2018)
Attributed to:
BALTI 2: The Beta-2 Agonist Lung Injury Trial 2
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/labinvest.2017.114
PubMed Identifier: 29083412
Publication URI: http://europepmc.org/abstract/MED/29083412
Type: Journal Article/Review
Volume: 98
Parent Publication: Laboratory investigation; a journal of technical methods and pathology
Issue: 1
ISSN: 0023-6837